CN¥ 12.46
Key Takeaways
Risk factor
Good trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Sichuan Huiyu Pharmaceutical Co., Ltd., established in 2010 and headquartered in Neijiang, China, is actively involved in the entire pharmaceutical process. This includes the research, development, manufacturing, and commercialization of medications. The company's core specialization is in anti-tumor therapies and injectable drugs, catering primarily to the oncology sector and related medical disciplines, but also extending its offerings to other therapeutic areas.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,
Data is available to registered users only